
Stemline Therapeutics (STML)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Stemline Therapeutics (STML) Stock
Start investing in Stemline Therapeutics (STML)
About Stemline Therapeutics (STML)
Market cap | $621.2M |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 1.9M |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | -7.47x |
Today's range | — |
Debt / equity | — |
52 week range | $3.21 - $18.22 |
5 year debt / equity | 0.03x |
Beta (LTM) | 1.08x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | Mar 13, 2020 |
Dividend payable date | — |
Stemline Therapeutics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy STML stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in STML stock
Navigate to the Explore page. Then, type STML into the search bar. When you see STML stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased STML stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Stemline Therapeutics Stock Earnings
The value each STML share was expected to gain vs. the value that each STML share actually gained.
Stemline Therapeutics (STML) reported Q4 2019 earnings per share (EPS) of -$0.38, missing estimates of -$0.35 by 8.57%. In the same quarter last year, Stemline Therapeutics's earnings per share (EPS) was $0. Stemline Therapeutics is expected to release next earnings on 03/13/2020, with an earnings per share (EPS) estimate of $0.